| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.8 | 0.6 |
| Profit before tax | -21.9 | -24.3 |
| Net income | -21.9 | -23.5 |
| EPS (diluted, $ a share) | $-0.29 | $-0.44 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +30.1% |
|---|
10-Q filed with the SEC, NASDAQ: CBUS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Cibus, Inc.: key numbers
- Share price
- $1.20Close, Nov 16
- Sector
- Industrial Applications and Services
- Industry
- Agricultural ChemicalsSIC 2870
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Cibus, Inc.
All →Cibus Financial Results
Cibus, Inc. reported financial results for the third quarter of 2026, highlighting progress in its rice herbicide-tolerance traits and the initiation of manufacturing for its first two biofragrance products. The company reduced its year-to-date cash usage by 19% year-over-year and expects to exit 2026 with an annualized net cash usage run rate of approximately $35 million.
- Term
- Q3 2026
“Three months ago I described three ways our platform creates value: platform programs that generate revenue today, royalties as our traits reach acres, and partnerships that deepen over time. Each of these moved closer this quarter. We received requests from our customer for larger quantities of two biofragrance products to advance their product development. Our Rice traits performed well in Latin American field trials and are now being tested where it counts, in our customer Interoc's own varieties in its own fields. Further, a second partner-funded crop program, Mustard in India, began work in the quarter.”
Craig Wichner, Chief Executive Officer